Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
phytochemical |
| gptkbp:approvalYear |
2012
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A07XA06
|
| gptkbp:brand |
gptkb:Fulyzaq
|
| gptkbp:CASNumber |
142825-10-3
|
| gptkbp:derivedFrom |
gptkb:Croton_lechleri
|
| gptkbp:discoveredBy |
gptkb:Napo_Pharmaceuticals
|
| gptkbp:hasMolecularFormula |
C56H84O26
|
| https://www.w3.org/2000/01/rdf-schema#label |
Crofelemer
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
chloride channel inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
bronchitis
cough flatulence upper respiratory tract infection increased bilirubin |
| gptkbp:UNII |
Y8O3VT895D
|
| gptkbp:usedFor |
treatment of non-infectious diarrhea in HIV/AIDS patients
|
| gptkbp:bfsParent |
gptkb:Croton_lechleri
|
| gptkbp:bfsLayer |
7
|